Total planned funding: $766,679,267
Clear active filters
Tanzania
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Tanzania | $766,679,267 |
Organizational Types
| Private Contractor | $766,679,267 |
Program Areas
| Treatment | $419,287,571 |
| Care | $164,670,990 |
| Prevention | $102,670,308 |
| Governance and Systems | $44,585,361 |
| Testing | $18,929,649 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $221,416,639 |
| HTXS: Treatment: Adult Treatment | $174,226,249 |
| HKID: Care: Orphans and Vulnerable Children | $92,384,786 |
| HBHC: Care: Adult Care and Support | $41,634,110 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $36,609,743 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $35,850,298 |
| OHSS: Health Systems Strengthening | $29,840,667 |
| PDTX: Treatment: Pediatric Treatment | $23,644,683 |
| HVCT: Testing: HIV Testing and Counseling | $18,929,649 |
| HVTB: Care: TB/HIV | $18,584,255 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $14,769,708 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $14,560,229 |
| PDCS: Care: Pediatric Care and Support | $12,067,839 |
| HVSI: Strategic Information | $7,373,286 |
| HLAB: Laboratory Infrastructure | $7,371,408 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $680,330 |
| HMBL: Biomedical Prevention: Blood Safety | $200,000 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Chemonics International:
$270,554,210
Countries/Regions
Deloitte Consulting Limited:
$125,572,466
Countries/Regions
Pact, Inc.:
$95,655,616
Countries/Regions